Removal of Drugs for Alzheimer ’s Disease from the List of Reimbursable Drugs in France: Analysis of Change in Drug Use, Disease Management and Cognition Using the National Alzheimer Data Bank (BNA)
ConclusionThis study provides real-life information about the use of AD drugs after they were withdrawn from reimbursement in France and shows that drug discontinuation was limited among patients followed in memory centres and accompanied by increased use of other healthcare resources. (Source: Drugs and Aging)
Source: Drugs and Aging - January 7, 2021 Category: Geriatrics Source Type: research
Therapeutic Options Under Development for Nonneovascular Age-Related Macular Degeneration and Geographic Atrophy
AbstractAge-related macular degeneration (AMD) is a chronic, multifactorial disease and a leading cause of irreversible blindness in the elderly population in the Western Hemisphere. Among the two major subtypes of AMD, the prevalence of the nonneovascular (dry) type is approximately 85 –90% and the neovascular (wet) type is 10–15%. Healthy lifestyle and nutritional supplements of anti-oxidative micronutrients have been shown to delay the progression of dry AMD and lower the risk of development of wet AMD, and anti-vascular endothelial growth factor (anti-VEGF) injections have been shown to improve visual acuity for we...
Source: Drugs and Aging - December 23, 2020 Category: Geriatrics Source Type: research
Pharmacist Identification of Medication Therapy Problems Involving Cognition Among Older Adults Followed by a Home-Based Care Team
ConclusionsOur study findings support the role of pharmacists on multidisciplinary teams to identify cognitively harmful medications, dementia treatment side effects, and untreated cognitive conditions.Clinical Trial RegistrationClinicalTrials.gov NCT02945085. (Source: Drugs and Aging)
Source: Drugs and Aging - December 23, 2020 Category: Geriatrics Source Type: research
Treatment of Seizures in Older Patients with Dementia
AbstractThe numbers of patients with dementia and patients with epilepsy are increasing in the global population. In fact, these two conditions are related, and it is estimated that at least 5 –10% of seizures or epilepsy in older individuals (aged> 60 years) are caused by a neurodegenerative dementia. In the vast majority, one of the four following diseases is involved: Alzheimer’s disease, Lewy body dementia, frontotemporal dementia, or vascular dementia. These diseases cause, not only seizures or epilepsy in affected patients, but cognit ive, behavioral, and motor disorders as well. As a result, the challenges ...
Source: Drugs and Aging - December 14, 2020 Category: Geriatrics Source Type: research
Nurses ’, Pharmacists’ and Family Physicians’ Perceptions of Psychotropic Medication Monitoring in Australian Long-Term Care Facilities: A Qualitative Framework Analysis
Conclusions and ImplicationsPsychotropic monitoring is perceived by all HCPs as a shared responsibility; however, the conceptualization of monitoring differs between HCPs. HCPs ’ beliefs and attitudes require consideration when designing implementation strategies for interventions to ameliorate suboptimal monitoring practices. (Source: Drugs and Aging)
Source: Drugs and Aging - December 14, 2020 Category: Geriatrics Source Type: research
